Continuous Glucose Monitors (CGMs): Are They Worth It for Non-Diabetics?

Continuous glucose monitors were, until recently, a clinical tool reserved exclusively for people with type 1 diabetes. Today, they are available over the counter in the UK and are increasingly used by people without diabetes who want real-time data about how their body responds to food, sleep, exercise, and stress. But are they genuinely useful for people without a diabetes diagnosis — or are they an expensive piece of tech that generates anxiety without actionable insight? Here is a balanced, evidence-based look.

What Is a Continuous Glucose Monitor?

A CGM is a small wearable sensor — typically applied to the upper arm or abdomen — that measures glucose in the interstitial fluid (the fluid surrounding cells just beneath the skin). It takes a glucose reading approximately every one to five minutes and transmits the data to a smartphone app or a dedicated reader.

Unlike fingerprick glucometers, CGMs show a continuous glucose curve, including the direction and rate of change. You can see exactly how your glucose responds in real time to a bowl of porridge, a glass of wine, a walk, or a poor night's sleep.

In the UK, the most widely used devices for non-clinical use are the Abbott FreeStyle Libre (particularly the Libre 2 and Libre 3) and the Dexcom One. Both are available without prescription — the Libre can be purchased at most major pharmacies.

What Can a CGM Tell You That a Fingerprick Test Cannot?

A standard fingerprick test gives you a single snapshot — your glucose at one moment in time. A CGM gives you a film: a continuous curve showing how your glucose rises and falls throughout the day and night.

With this data, you can learn which specific foods cause sharp spikes and which produce a gentle rise; whether you experience a significant post-meal glucose crash (reactive hypoglycaemia); how exercise affects your glucose in real time; whether your sleep quality correlates with your next-day glucose patterns; how stress or illness affects your metabolic response; and whether you experience nocturnal hypoglycaemia (low blood sugar during sleep).

For people with prediabetes or early insulin resistance, this information can be genuinely motivating and educational — turning abstract concepts about glycaemic index into visible, personal feedback.

The Evidence for CGMs in Non-Diabetics

The evidence for CGM use specifically in non-diabetic populations is still emerging. A 2023 review in The Lancet noted that CGM data in metabolically healthy individuals reveals significant inter-individual variation in glucose responses to the same foods — challenging the idea that a universal GI table applies equally to everyone.

The ZOE study (Personalised Nutrition Project), one of the largest nutritional science studies using CGMs in non-diabetics, found that postprandial glucose response is highly personalised — two people eating identical meals can have very different glucose curves. This suggests that CGM data could help people identify their own optimal food patterns.

However, the same study acknowledged limitations: CGM data can be difficult to interpret without guidance, and acting on it without clinical support may lead to unnecessary dietary restriction or health anxiety.

Honest Limitations to Consider

CGMs are not perfectly accurate. Interstitial glucose lags behind blood glucose by approximately 5 to 15 minutes — this is a physiological reality, not a device flaw — but it means readings during rapid glucose changes can appear higher or lower than they truly are.

Reference ranges used in clinical practice are designed for venous blood glucose (fingerprick or laboratory), not interstitial fluid. A CGM reading of 8.5 mmol/L is not equivalent to a laboratory reading of 8.5 mmol/L.

There is also the question of psychological impact. Some people find that continuous data empowers them to make positive changes. Others find that watching their glucose rise after every meal generates disproportionate anxiety — leading to overly restrictive eating without meaningful health benefit. A 2023 study in Diabetes Technology & Therapeutics found that CGM use in non-diabetics was associated with increased dietary restriction behaviours in some participants.

Cost is also a practical factor. A Libre sensor lasts 14 days and costs approximately £49. Regular use adds up to over £1,000 per year — without the NHS subsidy available to diabetic patients.

Key Takeaways

A CGM can be a genuinely educational tool for someone wanting to understand their personal metabolic response to food and lifestyle — particularly if they have prediabetes, are on a structured nutrition programme, or simply want data-driven insight. However, it is not necessary for most healthy adults, and the data should be interpreted in context. If you do try one, use it as a learning tool rather than a source of daily anxiety, and discuss any concerning patterns with your GP rather than self-diagnosing.